Please wait
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Apeiron Investment Group Ltd.

(Last) (First) (Middle)
66 & 67, BEATRICE, AMERY STREET,

(Street)
SLIEMA O1 SLM1707

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2024
3. Issuer Name and Ticker or Trading Symbol
BIONOMICS LTD/ADR [ BNOX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1) 183,121,441 I By Apeiron Investment Group Ltd.(2)
Ordinary Shares(1) 93,369,060 I By Apeiron Presight Capital Fund II, L.P.(3)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Apeiron Investment Group Ltd.

(Last) (First) (Middle)
66 & 67, BEATRICE, AMERY STREET,

(Street)
SLIEMA O1 SLM1707

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Apeiron Presight Capital Fund II, L.P.

(Last) (First) (Middle)
66 & 67, BEATRICE, AMERY STREET,

(Street)
SLIEMA O1 SLM1707

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Angermayer Christian

(Last) (First) (Middle)
66 & 67, BEATRICE, AMERY STREET,

(Street)
SLIEMA O1 SLM1707

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Includes Ordinary Shares represented by American Depositary Shares.
2. The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
3. The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.
Remarks:
The Reporting Persons were unaware that the Issuer ceased to be a foreign private issuer as of July 1, 2024, resulting in this delinquent report on Form 3.
Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director 10/07/2024
Apeiron Presight Capital Fund II, L.P. By: /s/ Fabian Hansen, Managing Member of General Partner 10/07/2024
/s/ Christian Angermayer 10/07/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.